GRTX - Galera Therapeutics GAAP EPS of -$0.48 August, 14 2023 09:48 AM Galera Therapeutics Inc. 2023-08-14 09:48:53 ET Galera Therapeutics press release ( NASDAQ: GRTX ): Q2 GAAP EPS of -$0.48. As of June 30, 2023, Galera had cash, cash equivalents and short-term investments of $38.8 million. For further details see: Galera Therapeutics GAAP EPS of -$0.48